Schott, Gisela <br/><br/>
The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.  [electronic resource] 

 -  Deutsches Arzteblatt international  Apr 2010 
 - 295-301 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1866-0452 
<br/><br/><label>Standard No.: </label>10.3238/arztebl.2010.0295  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Access to Information<br/>Authorship<br/>Clinical Trials as Topic<br/>Conflict of Interest<br/>Data Collection<br/>Drug Industry<br/>Germany<br/>Humans<br/>Publishing<br/>Research Support as Topic